News on Computational Toxicology and Bioinformatics Labhttps://omixlab.mu-sofia.bg/news/Recent content in News on Computational Toxicology and Bioinformatics LabHugo -- 0.165.0enWed, 01 Jul 2026 00:00:00 +0000Building multi-omics capacity through Erasmus+ training at the University of Viennahttps://omixlab.mu-sofia.bg/news/2026-07-erasmus-vienna-proteomics/Wed, 01 Jul 2026 00:00:00 +0000https://omixlab.mu-sofia.bg/news/2026-07-erasmus-vienna-proteomics/Assoc. Prof. Yordan Yordanov completed hands-on Erasmus+ training in untargeted mass-spectrometry proteomics at the Gerner Lab, University of Vienna.From an MSc research question to a reproducible open-science workflowhttps://omixlab.mu-sofia.bg/news/2026-06-19-pharmacia-image-analysis-paper/Fri, 19 Jun 2026 00:00:00 +0000https://omixlab.mu-sofia.bg/news/2026-06-19-pharmacia-image-analysis-paper/A new Pharmacia paper connects SH-SY5Y neurite morphology, PhaseContrastNeuriteAnalyzer, open code and a FAIR-oriented microscopy dataset.AI in biomedical data analysis at the INGENIUM Blended Intensive Programmehttps://omixlab.mu-sofia.bg/news/2026-06-01-ingenium-ai-biomedical-data/Mon, 01 Jun 2026 00:00:00 +0000https://omixlab.mu-sofia.bg/news/2026-06-01-ingenium-ai-biomedical-data/Assoc. Prof. Yordan Yordanov lectured on AI in biomedical data analysis during the INGENIUM Blended Intensive Programme at Medical University - Sofia.How safe are the medicines we take?https://omixlab.mu-sofia.bg/news/2026-05-29-medicine-safety-podcast/Fri, 29 May 2026 00:00:00 +0000https://omixlab.mu-sofia.bg/news/2026-05-29-medicine-safety-podcast/Assoc. Prof. Yordan Yordanov was a guest on the Bulgarian science podcast ‘You and Science’ for a discussion on medicines, benefit-risk balance and preclinical safety.Contributing to the OpenTox 2026 internship programmehttps://omixlab.mu-sofia.bg/news/2026-05-12-opentox-internships/Tue, 12 May 2026 00:00:00 +0000https://omixlab.mu-sofia.bg/news/2026-05-12-opentox-internships/MU OmicsLab contributed supervision topics to the OpenTox 2026 Summer/Autumn Internship Programme in AI, toxicology and biomedical data science.MU OmicsLab at the first CardioPharmaGENET Annual Meeting in Darmstadthttps://omixlab.mu-sofia.bg/news/2026-05-11-cardiopharmagenet-annual-meeting/Mon, 11 May 2026 00:00:00 +0000https://omixlab.mu-sofia.bg/news/2026-05-11-cardiopharmagenet-annual-meeting/Assoc. Prof. Yordan Yordanov represented Medical University - Sofia at the first CardioPharmaGENET Annual Meeting in Darmstadt.PhaseContrastNeuriteAnalyzer and open microscopy dataset releasedhttps://omixlab.mu-sofia.bg/news/2026-04-17-phasecontrastneuriteanalyzer-dataset/Fri, 17 Apr 2026 00:00:00 +0000https://omixlab.mu-sofia.bg/news/2026-04-17-phasecontrastneuriteanalyzer-dataset/PhaseContrastNeuriteAnalyzer was released together with a 5.8-GB open microscopy dataset supporting reproducible analysis of SH-SY5Y neurite morphology.AOPxGeneNet beta connects transcriptomic networks with adverse outcome pathwayshttps://omixlab.mu-sofia.bg/news/2026-02-27-aopxgenenet-beta/Fri, 27 Feb 2026 00:00:00 +0000https://omixlab.mu-sofia.bg/news/2026-02-27-aopxgenenet-beta/A beta version of AOPxGeneNet was released to help connect transcriptomic network analysis with the adverse outcome pathway framework.Integrating co-expression networks with adverse outcome pathways in Parkinson's diseasehttps://omixlab.mu-sofia.bg/news/2025-12-01-opentox-parkinsons-aop-talk/Mon, 01 Dec 2025 00:00:00 +0000https://omixlab.mu-sofia.bg/news/2025-12-01-opentox-parkinsons-aop-talk/Assoc. Prof. Yordan Yordanov presented OmicsLab work on WGCNA, AOPs and Parkinson’s disease at the OpenTox Virtual Conference 2025.Student-led MSc project recognized for research on SH-SY5Y differentiationhttps://omixlab.mu-sofia.bg/news/2025-12-01-shsy5y-msc-recognition/Mon, 01 Dec 2025 00:00:00 +0000https://omixlab.mu-sofia.bg/news/2025-12-01-shsy5y-msc-recognition/A student-led MSc thesis on rosmarinic and retinoic acid effects in SH-SY5Y cells was recognized and later became part of a broader open-science research trajectory.CardioPharmaGENET COST Action beginshttps://omixlab.mu-sofia.bg/news/2025-10-29-cardiopharmagenet-cost-action-launch/Wed, 29 Oct 2025 00:00:00 +0000https://omixlab.mu-sofia.bg/news/2025-10-29-cardiopharmagenet-cost-action-launch/The CardioPharmaGENET COST Action began its four-year programme, connecting MU OmicsLab interests in data analysis, omics and AI with a European pharmacogenomics network.